510(k) Report

510(k) · Cleared

Cleared

Integrity, Model V500

K043396510(k) TraditionalCleared Jan 24, 200545-day reviewClass II21 CFR 882.1900

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Vivosonic, Inc. · GWJ Stimulator, Auditory, Evoked Response

Cleared on Jan 24, 2005 after a 45-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Jan 24, 2005
Review
45 days
Class
Class II
Product code
GWJ
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K043396Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GWJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWJ device

  1. #1 K242954 Integrity V500 (Integrity, Integrity with VEMP)score 10.0 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All GWJ devices

GWJ Stimulator, Auditory, Evoked Response: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · GWJ

2in 2024

2007: 22008: 42009: 42010: 12011: 22012: 12013: 22014: 22015: 12017: 22020: 12021: 12022: 12024: 2
2007high 4 (2008) · low 0 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWJ

111in 2009

2008: 64 days median2009: 111 days median
2007high 111 (2009) · low 64 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GWJ

1in 2025

2008: 12010: 12019: 12025: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GWJ

1in 2025

2010: 22011: 52012: 12013: 12015: 32016: 12017: 432018: 242019: 52020: 32021: 32022: 82023: 62024: 72025: 1
2007high 43 (2017) · low 0 (2007)2025

MAUDE reports naming product code GWJ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
200846410
2009411100
20101—12
20112—05
20121—01
20132—01
20142—00
20151—03
20160—01
20172—043
20180—024
20190—15
20201—03
20211—03
20221—08
20230—06
20242—07
20250—11
20260—0—

What is it indicated for?

DPOAE and TEOAE Test Option The Integrity V500 with DPOAE and TEOAE test options is indicated for use when it is necessary for a trained health care professional (for example, an Audiologist) to measure or determine cochlear function by measuring, recording, and displaying otoacoustic emissions. This device does not measure hearing, but helps to determine whether or not a hearing loss may be present, requiring further evaluation. DPOAE and TEOAE tests do…

Read the full statement (135 words)

DPOAE and TEOAE Test Option

The Integrity V500 with DPOAE and TEOAE test options is indicated for use when it is necessary for a trained health care professional (for example, an Audiologist) to measure or determine cochlear function by measuring, recording, and displaying otoacoustic emissions. This device does not measure hearing, but helps to determine whether or not a hearing loss may be present, requiring further evaluation.

DPOAE and TEOAE tests do not measure hearing per se, but measure whether or not the cochlear hair cells are functioning. This device does not determine hearing levels, but allows the operator to establish specific pass or refer criteria.

ABR/ASSR Test Option

The Integrity V500 with ABR/ASSR options is indicated for auditory evoked potential testing as an aid in detecting hearing loss and lesions in the auditory pathway.

Indications for use as stated in the FDA 510(k) statement.

Cite this page

510(k) Report. “K043396: Integrity, Model V500.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K043396

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026